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Reactive Oxygen Species (ROS) can cause oxidative damage and have been proposed
to be the main cause of aging and age-related diseases including cancer, diabetes
and Parkinson’s disease. Accordingly, mitochondria from old individuals have higher
levels of ROS. However, ROS also participate in cellular signaling, are instrumental for
several physiological processes and boosting ROS levels in model organisms extends
lifespan. The current consensus is that low levels of ROS are beneficial, facilitating
adaptation to stress via signaling, whereas high levels of ROS are deleterious because
they trigger oxidative stress. Based on this model the amount of ROS should determine
the physiological effect. However, recent data suggests that the site at which ROS
are generated is also instrumental in determining effects on cellular homeostasis. The
best example of site-specific ROS signaling is reverse electron transport (RET). RET is
produced when electrons from ubiquinol are transferred back to respiratory complex I,
reducing NAD+ to NADH. This process generates a significant amount of ROS. RET has
been shown to be instrumental for the activation of macrophages in response to bacterial
infection, re-organization of the electron transport chain in response to changes in energy
supply and adaptation of the carotid body to changes in oxygen levels. In Drosophila
melanogaster, stimulating RET extends lifespan. Here, we review what is known about
RET, as an example of site-specific ROS signaling, and its implications for the field of
redox biology.
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INTRODUCTION
Mitochondrial reactive oxygen species (mtROS) produced by the respiratory chain (RC) during
oxidative phosphorylation are the main source of free radicals in most cell types. The scientific
community has changed its opinion of ROS over the last 15 years. Initially ROS were described
as simple by-products of metabolism that caused oxidative damage and were responsible for
damage upon ischemia-reperfusion or chronic diseases such as Parkinson’s or Alzheimer’s disease
as well as aging (Sanz et al., 2006). However, an increasing amount of evidence has shown that
mtROS play a more complex role than previously anticipated, actively participating in cellular
signaling. For example hydrogen peroxide (H2O2), a stable ROS, is able to diffuse far away from
the mitochondrion and alter the activity of proteins by regulating the oxidative state of one or more
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cysteine residues. This type of redox regulation has been shown
to be instrumental in controlling many physiological processes
(Bak and Weerapana, 2015). Furthermore, several independent
reports have shown that boosting mtROS delays aging and the
onset of age-related diseases (Hekimi et al., 2011).
The current consensus is that the amount of ROS determines
their physiological effects, with low levels of ROS having
beneficial effects through stimulation of mitohormesis and high
levels causing oxidative damage and contributing to aging. In
the last 10 years, the development of new technology and
methods has allowed the measurement of mtROS levels in
more physiological conditions (Cocheme et al., 2011). Evidence
collected using these new techniques indicates that the site at
which ROS are generated is as important as the amount of ROS
produced.
In mitochondria isolated from rat skeletal muscle 11 different
sites at which electrons can leak to produce ROS have been
described (Brand, 2016). The amount of ROS produced at each
of these sites depends on experimental conditions, including the
concentration and combination of substrates used to feed the RC.
Experiments performed in vitro designed to mimic the cytosolic
environment of the muscle (Goncalves et al., 2015) show that
the main sites of ROS generation are respiratory complexes I
(aka NADH:ubiquinone oxidoreductase, CI), II (aka succinate-
coenzyme Q reductase, CII) and III (aka ubiquinol:cytochrome
c oxidoreductase, CIII). Unfortunately, there are currently few
studies describing how much ROS each respiratory complex
produces in vivo due to the lack of resolution with these type
of measurements (reviewed in Sanz, 2016). Existing data from in
vivo studies seem to confirm data from in vitrowork, with amajor
role for respiratory CI and CIII in ROS production (Chouchani
et al., 2014; Scialo et al., 2016). CI generates ROS exclusively
into the mitochondrial matrix, while CIII can produce ROS into
either the matrix or intermembrane space. The impact of ROS
generated at CIII on cellular physiology has been extensively
reviewed elsewhere (Sena and Chandel, 2012). For the sake of
space, we will focus on ROS produced by CI and particularly on
ROS produced via Reverse Electron Transport (RET). Although
antioxidant scavenging will modulate the intensity of a ROS
signal and the impact on levels of oxidative stress, we will
not discuss the role of the several antioxidant systems cells
have evolved to prevent oxidative damage and modulate ROS
signaling. Instead, we refer readers to some excellent reviews
published on this topic (Droge, 2002; Sena and Chandel, 2012).
Until recently, RET was considered as an in vitro artifact
with no relevance in vivo. However, in the last 10 years several
groups have independently published evidence that does occur
RET in vivo and that it has a central role in many physiological
processes, including aging. Here, we review what is known about
RET in vivo including how it is induced and the downstream
physiological effects of RET activation.
HOW DOES RET OCCUR IN VIVO?
In 1961, Chance and Hollunger (1961) described a previously
unknown mechanism by which isolated mitochondria produce
NADH from NAD+ after supplying them with succinate (a
complex II substrate). Later, it was shown that CI reduces
NAD+ to NADH with electrons received from ubiquinol via
reverse electron transfer (RET). Interestingly, RET is associated
with the generation of high levels of ROS. Now we know
that RET occurs when the pool of coenzyme Q (CoQ)
becomes over-reduced with electrons from respiratory complex
II (aka succinate dehydrogenase, CII) (Chouchani et al., 2014).
It is possible that other enzymes that introduce electrons
downstream of CI such as glycerol-3-phosphate dehydrogenase,
electron-transferring flavoprotein (ETF-QO) or dihydroorotate
dehydrogenase (DHODH) also contribute to RET generation
(Figure 1). Blocking CIII or CIV may also generate conditions
for RET. Indirect evidence indicates that nitric oxide inhibits CIV
and triggers RET in cell culture (Taylor and Moncada, 2010).
However, to the best of our knowledge there is no evidence that
this occurs in vivo. CoQ plays a major role in mitochondrial
respiration since all electrons introduced into the RC will reduce
ubiquinone to ubiquinol (Lopez-Lluch et al., 2010). Ubiquinol
transfers electrons to CIII becoming re-oxidized to ubiquinone
in the process. Since CoQ plays such an essential role, it is
not surprising that the most important steps in its synthesis
occur within the mitochondrion in a multi-enzyme complex that
requires the products of between 10 and 11 genes to be assembled
(Bentinger et al., 2010). Mutations in any of these genes can cause
severe CoQ deficiency that affects mitochondrial physiology and
cellular homeostasis (Fernandez-Ayala et al., 2013). Whether this
is caused by alterations in ROS levels remains controversial.
In any case, secondary alterations in CoQ synthesis that can
alter ROS levels including ROS produced via RET are frequently
associated with mitochondrial disease (Fernandez-Ayala et al.,
2014).
In addition to a high ratio of ubiquinol to ubiquinone, a
high proton motive force (1p) is required to produce RET.
How a sufficiently high 1p is generated or maintained to allow
RET in vivo remains to be determined. It has been suggested
that when RET occurs CV stops producing ATP (Mills et al.,
2016). The phosphorylation activity of complex V (CV) could be
modulated by ATPIF1. When mitochondrial electron transport
is interrupted, CV alters the way it operates, transferring
protons from the matrix to the intermembrane space. This
process maintains 1p, preventing cell death, but consuming
ATP. ATPIF1 inhibits this reverse transfer of protons and thus
prevents the depletion of ATP (Esparza-Molto et al., 2017). It
has been proposed that ATPIF1 can bind to CV in normal
conditions (i.e. when protons flow from the intermembrane
space to the matrix) inducing a ROS signal (Esparza-Molto
et al., 2017). In these conditions, ROS are probably produced via
RET however experimental evidence supporting this is missing.
Another possible mechanism for inhibition of CV and induction
of RET is via the Krebs’ cycle intermediate alpha-ketoglutarate. In
a ground-breaking study published in Nature (Chin et al., 2014),
Chin and col. demonstrated that alpha-ketoglutarate can inhibit
CV and extend lifespan in Caenorhabidtis elegans. Although, the
mechanism that elicited lifespan extension was not described in
detail, we can suggest it may be connected to ROS produced via
RET as has been shown in Drosophila melanogaster (see below).
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FIGURE 1 | Respiratory CI produces ROS in both the forward and reverse direction. (A) During forward electron transfer (FET), CoQ receives electrons from
complexes I and II, DHODH, G3P and ETFQO. During this process electrons mainly leak to produce superoxide from the IF site of CI during the oxidation of NADH to
NAD+. (B) In these conditions, if rotenone blocks the IQ site, electrons cannot be transferred to CoQ, leak and generate ROS. FCCP also increases mtROS generation
during FET. (C) When the CoQ pool becomes over-reduced, a high membrane potential favors the reverse transfer of electrons from ubiquinol to CI in a process called
reverse electron transport (RET). During RET electrons leak at either IF or IQ generating a significant amount of superoxide. (D) Blocking the IQ site with rotenone
during RET prevents CoQ from transferring electrons back to CI and reduces ROS production. Similarly, FCCP reduces ROS by dissipating membrane potential.
WHERE ARE ROS PRODUCED WITHIN CI?
One important question that needs to be addressed is where
electrons leak from to produce ROS within CI (Hirst et al., 2008).
Various studies have addressed this question using purified CI,
sub-mitochondrial particles or isolated mitochondria. CI, with
an approximate size of 1 MDa, is made up of 45 subunits. It
has a hydrophobic domain responsible for proton pumping and
a hydrophilic domain involved in electron transfer (Zhu et al.,
2016). Seven iron-sulfur centers transfer electrons between the
flavin mononucleotide (FMN, site IF), where NADH is oxidized
to NAD+, and the Q-binding site (IQ) where electrons are finally
transferred to ubiquinone (Figure 1). IF, IQ and the iron-sulfur
cluster N2 have been proposed to produce superoxide (Scialo
et al., 2013).
CI can produce ROS when electrons circulate in the forward
or reverse direction. When CI-linked substrates (i.e., glutamate
or pyruvate in combination with malate) are used to feed the
RC, electrons circulate through CI in the forward direction.
In these conditions, blocking the IQ site with rotenone causes
accumulation of NADH and over-reduction of the IF site, where
electrons leak to reduce oxygen to superoxide (Murphy, 2009).
This electron leak and subsequent superoxide formation is
independent of both the redox state of CoQ and 1p. When
CII-linked substrates (i.e., succinate) are used, a portion of the
electrons flow through CI in the reverse direction. ROS produced
in these conditions depend on the redox state of CoQ and
1p, with both rotenone and FCCP significantly reducing ROS
produced via RET. It is not clear fromwhere electrons leak during
RET, although IQ has been proposed as the most probable site of
electron leak (Brand et al., 2016).
Understanding where ROS are produced within CI is not only
an academic matter. An interesting study from the laboratory
of Stefan Drose demonstrated that how ROS are generated
(i.e., in forward or reverse direction) at CI affects how several
proteins are oxidized (Bleier et al., 2015). This supports the
existence of site-specific ROS signaling that activates specific
pathways by altering the redox states of specific proteins. This
means that stimulating the generation of ROS at specific sites
and preventing electron leak from others could have therapeutic
effects. Following this logic, Martin Brand’s group has started to
design antioxidants that target ROS produced exclusively by CI
(Brand et al., 2016) or CIII (Orr et al., 2015). In relation to this,
we should also discuss rotenone and metformin. Although both
rotenone and metformin can inhibit CI, they have very different
physiological effects. For example, rotenone exposure causes a
Parkinson’s like phenotype in animal models, whereas metformin
is used to treat diabetes (Celardo et al., 2014). It is not clear where
metformin inhibits CI (i.e., IF or IQ) or whether its therapeutic
properties are related with the inhibition of CI. However, it is
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possible that the positive effects of metformin are caused by a
site-specific inhibition of CI that triggers a specific ROS signal.
Given the therapeutic potential of metformin, this possibility
should be carefully tested in future. As we will discuss below, ROS
produced via RET at CI (RET-ROS) have the potential to be a
major signaling pathway between the mitochondrion and the rest
of the cell. In normal conditions, this system would contribute
to maintaining cellular homeostasis but when dysregulated could
result in several pathological effects.
REVERSE ELECTRON TRANSPORT IN
HEALTH
ROS play an essential role in redox signaling (Reczek and
Chandel, 2014). As we previously mentioned, the dominant
paradigm is that the amount of ROS determines physiological
effects. However, in addition to the amount of ROS, the site
at which ROS are generated is also important. RET-ROS is
particularly well suited to detecting metabolic changes which
require metabolic adaptations. RET is sensitive to changes in the
redox state of CoQ, which is directly related to electron flow
through the RC, and variations in 1p that relate to the capacity
to produce ATP. In addition, a considerable amount of ROS is
produced from RET. These RET-ROS could act as a signal whose
intensity could be modulated.
In recent years, RET-ROS have been implicated in several
physiological processes. Firstly, the differentiation of myoblasts
into myotubes requires an increase in mtROS levels which if
prevented with antioxidant treatment inhibits differentiation
(Lee et al., 2011). Importantly, rotenone, which increases
ROS production in the forward direction, but decreases ROS
production via RET (Figure 1) also inhibits differentiation (Lee
et al., 2011). Similarly, knock down of CI subunits which prevents
the assembly of the full complex and decreases RET (Scialo et al.,
2016), also reduces myoblast differentiation (Lee et al., 2011).
The Enriquez group, at CNIC in Madrid, has recently shown that
CI produces ROS in the forward or reverse direction depending
on the substrates used to feed the RC. Respiratory complexes
are organized in larger superstructures called supercomplexes.
Depending on the source of energy available (e.g. sugars or
fats), supercomplexes are present in different organizations i.e.
CI+CIII+CIV, CI+CIII and CIII+CIV, in addition to CIV alone
(Lapuente-Brun et al., 2013). The organization adopted will
maximize the use of the available fuel. Oxidation of glucose
produces NADH and FADH2 with five NADH molecules being
oxidized for each molecule of FADH2 by the RC. When fatty
acids are oxidized the ratio of NADH to FADH2 changes to 2:1
which results in an over-reduction of CoQ pool and an increase
in RET-ROS (Guaras et al., 2016). In these conditions, RET-
ROS promotes the degradation of CI increasing the association
between CIII and CIV, which is more efficient for the oxidation
of fatty acids. These results resolve many contradictory findings
regarding the effect of rotenone on levels of mtROS. As Guaras
and col. show (Guaras et al., 2016), rotenone increases ROS when
cells are fed with galactose, where ROS are produced in the
forward direction by CI, and reduces ROS when cells are fed with
fatty acids that stimulate production of RET-ROS (Figure 2).
In response to bacterial infection, macrophages reorganize
their RC, decreasing the levels of CI and increasing activity
of CII (Garaude et al., 2016). These changes are required to
produce an inflammatory response characterized by production
of pro-inflammatory cytokines such as interleukin 1β (IL-
1β) and IL-10. This suggests that both re-organization of the
RC and production of cytokines are elicited via production
of RET-ROS. Accordingly, Mills and col. have shown that
macrophages alter the way ROS are produced in response
to activation by lipopolysaccharide (LPS) (Mills et al., 2016).
To achieve this, macrophages interrupt ATP production via
oxidative phosphorylation (switching to producing ATP via
glycolysis), boost oxidation of succinate by CII and increase
mitochondrial membrane potential, subsequently triggering the
production of RET-ROS. Suppression of RET-ROS by preventing
oxidation of succinate, blocking RETwith rotenone or ectopically
expressing an alternative oxidase from Ciona intestinalis (that
prevents the over-reduction of CoQ Scialo et al., 2016) inhibits
the generation of pro-inflammatory cytokines required to fight
bacterial infection. These results indicate that RET-ROS signaling
is instrumental for metabolic and immune reprogramming
of macrophages and thus the initiation of an inflammatory
response.
Another important physiological phenomenon that seems to
be regulated by RET-ROS signaling is the sensing of oxygen
levels by the carotid body (CB) (Fernandez-Aguera et al., 2015).
The chemoreceptor cells of CB are responsible for inducing a
response to hypoxia. Under normoxia, CB cells use NADH and
CI produces low levels of ROS in the forward direction. However,
under hypoxia, cells undergo a metabolic shift characterized by
increased utilization of succinate, which alters ROS production
from CI from the forward to the reverse direction (Fernandez-
Aguera et al., 2015). In this model, not only ROS but also a
boost in NADH levels is required to trigger the hypoxia response,
suggesting that RET-ROS signaling may require other signals to
elicit a physiological adaptation.
Finally, we have recently showed that induction of RET-ROS
in Drosophila extends lifespan (Scialo et al., 2016). Accumulation
of damage caused by mtROS has been proposed as one of the
main drivers of aging (Barja, 2013) althoughmost of the evidence
supporting this hypothesis is indirect and based on data from
studies using isolated mitochondria (reviewed in Sanz, 2016).
Several laboratories have independently shown that increasing
ROS in animal models extends lifespan (Sanz, 2016), however
the downstream mechanisms that mediate lifespan extension
remain to be determined. Ectopic expression of NDI1 from
Saccharomyces cerevisiae in D. melanogaster increases the redox
state of CoQ causing a considerable elevation of mtROS levels
(Scialo et al., 2016). We observed that ROS were produced via
RET at CI, since feeding flies with rotenone or FCCP restored
ROS levels to normal. Moreover, co-expression of NDI1 with
AOX or knock down of a CI subunit (required for CI assembly)
had the same effect. Interestingly, co-expression of NDI1 with
a mitochondrially-targeted catalase abolished lifespan extension
conferred by NDI1 (Scialo et al., 2016), confirming that lifespan
was extended as a result of RET-ROS. Our work is the first
to clearly demonstrate that stimulation of RET-ROS in vivo
can extend lifespan in a complex animal, paving the way for
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FIGURE 2 | Reverse electron transfer (RET) as a new ROS-based mitochondrial signaling pathway. The redox state of the CoQ pool determines electron leak and
superoxide production and can be used by mitochondria as a signaling mechanism. Since RET is sensitive to changes in electron flow and membrane potential, it can
be used to detect changes in energy supply and fine-tune cell metabolism. For example, an increase in the availability fatty acid alters the NADH:FADH2 ratio from 5:1
to 2:1 and in response levels of CI are reshuffled by ROS produced via RET (RET-ROS) (Guaras et al., 2016).
stimulation of RET-ROS production as an anti-aging therapy. In
future, we are interested in determining how RET-ROS interact
with other signaling pathways that regulate lifespan, such as
insulin/insulin-like growth factor/Target of Rapamycin (Scialo
et al., 2015), to test whether they extend lifespan via the same or
distinct mechanisms.
REVERSE ELECTRON TRANSPORT IN
DISEASE
As we have discussed, RET-ROS signaling seems to be a
newly discovered signaling pathway, instrumental inmaintaining
cellular and organismal homeostasis. If this is indeed the
case, dysregulation of RET-ROS signaling will have pathological
consequences. Accordingly, oxidative damage and associated cell
death occurring during reperfusion (after an ischemic episode,
heart attack or stroke) in heart or brain is caused by an
excess of ROS produced via RET (Chouchani et al., 2014).
In a seminal study, the group of Mike Murphy, at the MRC
Mitochondrial Biology Unit in Cambridge, has shown that
succinate accumulates in ischemic tissues (Chouchani et al.,
2014). During reperfusion, succinate is rapidly oxidized by CII
producing RET-ROS, which cause oxidative damage leading
to cell death. Inhibition of CII with dimethyl-malonate or CI
with rotenone protects the heart during ischemia-reperfusion.
Similarly, a new generation of antioxidants that specifically
neutralize ROS produced at the IQ site within CI also alleviate the
effects of ischemia-reperfusion in the heart (Brand et al., 2016),
suggesting that specific protection against excess RET-ROS will
be beneficial in protecting against damage resulting from a heart
attack or stroke.
CONCLUSION
Mitochondria have evolved several ways to communicate with
the other cellular components in order to supply appropriate
amounts of energy and essential cellular components (e.g.
iron sulfur clusters) produced within the mitochondrion. The
entire set of molecules that participate in cellular signaling is
not well defined, but a number of transcription factors, RC
components, Krebs cycle intermediates and of course, ROS,
have been shown to be able to signal from mitochondria. ROS
as signaling molecules is particularly complicated since they
can cause oxidative damage. It is now widely accepted that
ROS participate in signaling at low levels, but cause damage
at higher concentrations. However, new evidence indicates that
the site at which ROS are generated is also important in
determining the effects of ROS. In fact, it follows logic that
ROS involved in signaling are produced in specific locations
at specific times. This pathway would rely on redox sensitive
proteins, located in proximity to the site of ROS production
to relay complex information. From this point of view, RET-
ROS signaling is an ideal system, since it detects changes in
membrane potential and electron flow, producing significant
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amount of ROS exclusively at CI. A number of independent
reports support a role for RET-ROS signaling in physiological
and pathological situations and even in the regulation of lifespan.
Further investigation using genetic tools and in vivo imaging will
help to determine the importance of RET-ROS signaling in health
and disease.
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